affiliation not provided to SSRN
Peripheral T-cell lymphoma, decitabine, azacytidine, tucidinostat, lenalidomide, CHOP, complete response rate, prognosis
Acute promyelocytic leukemia, PML::RARA fusion gene, measurable residual disease, the second consolidation therapy, relapse